Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Gastro Oesophageal Cancer × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 27 Prostatic Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Lung Neoplasms 12 Head and Neck Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Ovarian Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Adenocarcinoma of Lung 5 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Carcinoma 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

Oxaliplatin 1 Epirubicin 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01710592 2013-01-10

ELECT

Cancer Trials Ireland

Phase 2 Completed

Gastrointestinal

Gastro Oesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡